由于价格低廉, Eli Lilly拒绝将糖尿病药物Mounjaro列入澳大利亚的补贴名单. Eli Lilly rejects listing diabetes drug Mounjaro on Australia's subsidy list due to low pricing.

艾利·莉里公司拒绝将其糖尿病药物穆罗列入澳大利亚政府补贴名单, 使约45万患者无法使用. Eli Lilly has rejected a request to include its diabetes drug Mounjaro on Australia’s government subsidy list, leaving about 450,000 patients without access. 公司称政府的价格太低, 不能维持. The company cited the government’s proposed price as too low and unsustainable, while the advisory committee had recommended the drug’s inclusion. 这场僵局凸显了关于药品价格和基本药品获取的持续争议。 This standoff highlights ongoing disputes over drug pricing and access to essential medicines.